Hematologic cancers and complex blood disorders represent a major and growing global health challenge. According to the World Health Organization, cancers of the blood and lymphatic system, including leukemia, lymphoma, and multiple myeloma, account for a substantial share of cancer-related illness worldwide. Advances in diagnostics and therapy have improved outcomes for many patients, but they have also increased the need for highly specialized physicians trained in both hematology and oncology. Oncohematologists play a central role in diagnosis, risk assessment, treatment planning, and long-term follow-up for these conditions.
The Czech Republic delivers oncohematology care within a regulated healthcare system aligned with European Union medical standards. Physicians in this field complete medical school, followed by structured training in internal medicine, hematology, and oncology, with years of supervised clinical practice in accredited centers. Many specialists also pursue focused training in areas such as bone marrow transplantation, molecular diagnostics, or targeted and immunologic therapies. Clinical decision making is guided by internationally recognized protocols that emphasize diagnostic accuracy, stepwise treatment planning, and patient safety.
Oncohematology services are provided through large academic hospitals, tertiary referral centers, and specialized cancer institutes across the Czech Republic. These facilities are equipped with advanced laboratory diagnostics, cytogenetic and molecular testing, infusion units, and supportive care services. Multidisciplinary collaboration is standard practice, involving pathologists, radiologists, transplant specialists, infectious disease teams, and psychosocial support professionals. This coordinated approach supports individualized care, particularly for patients with complex or high-risk disease.
For international patients, cost accessibility and healthcare infrastructure are important considerations. While treatment costs vary depending on diagnosis, therapy type, and hospital setting, consultations and many treatments in the Czech Republic are generally more affordable than in several Western European countries. This reflects healthcare system organization rather than differences in clinical standards. Treatment plans are personalized, taking into account disease subtype, response to prior therapy, overall health, and patient preferences.
A diagnosis of a blood cancer or serious hematologic disorder can be emotionally demanding. Czech oncohematology teams increasingly emphasize clear communication, shared decision-making, and psychological support alongside medical treatment. In summary, oncohematologists in the Czech Republic practice within a transparent, evidence-based system focused on safety, professional accountability, and patient-centered care.
The following specialists practice in the Czech Republic and are listed for informational purposes only. This is not a ranking or endorsement.
Prof. MUDr. Marek Trněný, MD
Specialization: Hematologic malignancies and lymphoma
Years of Experience: 30+ years
Prof. Trněný practices at the General University Hospital in Prague. His clinical focus includes lymphoma diagnosis and treatment, clinical research, and guideline-based management within an academic oncology setting.
MUDr. Tomáš Kozák, PhD
Specialization: Leukemia and bone marrow disorders
Years of Experience: 25+ years
Dr. Kozák works at the Institute of Hematology and Blood Transfusion in Prague. His work includes acute and chronic leukemias, myelodysplastic syndromes, and coordination of advanced diagnostic testing.
Prof. MUDr. Roman Hájek, PhD
Specialization: Multiple myeloma and plasma cell disorders
Years of Experience: 25+ years
Prof. Hájek practices at University Hospital Ostrava. He focuses on multiple myeloma treatment, including modern drug therapies and collaboration with transplant units.
MUDr. Jiří Mayer, PhD
Specialization: Clinical hematology and stem cell transplantation
Years of Experience: 30+ years
Dr. Mayer is based at the University Hospital Brno. His clinical work includes stem cell transplantation, hematologic malignancies, and long-term follow-up care.
MUDr. Zdeněk Král, MD
Specialization: Chronic hematologic diseases and supportive care
Years of Experience: 20+ years
Dr. Král practices at University Hospital Hradec Králové. His focus includes chronic leukemias, anemia management, and supportive treatment strategies.
MUDr. Petra Tesařová, MD
Specialization: Hemato-oncology and solid tumor overlap care.
Years of Experience: 25+ years
Dr. Tesařová works at the General University Hospital in Prague. Her practice includes coordination of hematologic and oncologic care within multidisciplinary cancer teams.
MUDr. Pavel Žák, PhD
Specialization: Thrombosis, coagulation disorders, and hematologic malignancies
Years of Experience: 30+ years
Dr. Žák practices at Charles University-affiliated hospitals, focusing on coagulation disorders and their interaction with malignant blood diseases.
MUDr. Martin Doubek, PhD
Specialization: Chronic lymphocytic leukemia and molecular hematology
Years of Experience: 15+ years
Dr. Doubek works at University Hospital Brno, specializing in chronic lymphocytic leukemia and personalized treatment planning based on molecular findings.
| Consultation Type | Estimated Cost |
| Oncohematologist consultation | $200–$400 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing care for blood cancer or complex hematologic disease abroad can feel overwhelming and requires careful consideration of medical, logistical, and personal factors. Many patients begin by seeking reliable information about clinical standards, communication, and regulatory oversight.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient safety protocols, and informed consent practices
Foreign patients should also consider the practical aspects of care. Visa or entry requirements depend on nationality and length of stay. Some treatments may require an initial stay of 7 to 14 days for evaluation, treatment initiation, or monitoring. While English support is common in major cancer centers, language barriers may occur outside large cities. Planning follow-up care with a hematologist or oncologist in your home country is essential for continuity and long-term disease management.
Patients considering oncohematology care in the Czech Republic can share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and a clear starting point for treatment planning.
What visa assistance is available for patients traveling to the Czech Republic for oncohematology care?
Visa requirements depend on your nationality and the expected length of stay. While general guidance may be available through facilitators, you should confirm official requirements with the Czech embassy or consulate before making travel arrangements.
Will I be able to communicate in English with oncohematologists in the Czech Republic?
Many major hematology and cancer centers offer English-speaking medical staff or professional interpreters. It is advisable to confirm language support in advance, especially if care is planned outside major cities.
How can I arrange an online consultation through Best Clinic Abroad with an oncohematologist in the Czech Republic?
You can request an online consultation through Best Clinic Abroad by sharing your medical records, laboratory reports, and diagnosis details. Best Clinic Abroad can help coordinate a remote consultation with a licensed oncohematologist to discuss your condition and care planning.
Are online consultations sufficient before starting treatment abroad?
Online consultations can help clarify general treatment approaches and planning considerations, but they do not replace in-person clinical evaluation. Final treatment decisions are usually made after physical examination and detailed diagnostic review.
What should I plan for follow-up care after returning home?
Before treatment, discuss follow-up needs with your specialist. Coordinating ongoing care with a local hematologist or oncologist is important for monitoring, supportive care, and long-term management.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.